Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩37.63T | 193.1x | -2.65 | ₩178,500 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.4% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩4.46T | -1,200.5x | -16.23 | ₩121,700 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.7% Upside | Upgrade to Pro+ | |
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.41T | ₩29,550 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.31T | -108.9x | 16.31 | ₩94,100 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.83T | -29.4x | 0.07 | ₩38,150 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12% Upside | Upgrade to Pro+ | |
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.69T | -35.3x | 5.46 | ₩101,000 | 7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.11T | 37.6x | 0.03 | ₩23,950 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩504.19B | ₩11,430 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩454.26B | -18.2x | 0.03 | ₩17,760 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩419.83B | -42.3x | -10.73 | ₩17,600 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩399.71B | ₩28,500 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩357.17B | ₩16,020 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩352.15B | -10.9x | 1.57 | ₩2,560 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩345.42B | -42.6x | 0.04 | ₩10,450 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩328.41B | -6.8x | 0.03 | ₩38,600 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩312.52B | -13.2x | 0.58 | ₩18,940 | 11.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curiox BioSystems | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩310.99B | -25.1x | -1.52 | ₩19,320 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellivery | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩248.38B | -0.44 | ₩6,680 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
PharmAbcine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩233.76B | -0.45 | ₩2,915 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩230.85B | -25x | -25.77 | ₩10,120 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bridge Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩209.96B | -4.1x | -0.28 | ₩4,095 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩206.48B | -4.3x | -0.07 | ₩4,625 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩195.33B | -35.1x | 0.17 | ₩2,290 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3Billion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩193.91B | ₩6,220 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩193.59B | -3.4x | 0.1 | ₩6,720 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩193.5B | -5.1x | -0.7 | ₩3,530 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩191.4B | -7.5x | 0.18 | ₩7,200 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ENCell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩191.1B | ₩18,120 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩184.21B | -39.5x | -0.78 | ₩5,640 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orientbio | Seoul | Healthcare | Biotechnology & Medical Research | ₩182.12B | -19.7x | ₩1,451 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
NKMAX | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩172.74B | 31.1x | 0.07 | ₩2,020 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | ₩171.23B | -2.3x | 0.07 | ₩2,130 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩168.3B | ₩15,680 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩157.67B | -7.7x | -3.16 | ₩15,990 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Onconic Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩151.58B | ₩14,330 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Panagene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩127.83B | -10.9x | ₩3,060 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
HEM Pharma | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩126.5B | ₩17,560 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
CJ Bioscience | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩126.47B | -4.7x | -0.1 | ₩9,730 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DNA Link | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩118.04B | -9.1x | 0.17 | ₩5,490 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩117.39B | -6.3x | -0.13 | ₩3,450 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Noul | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩116.2B | -5x | -0.3 | ₩3,165 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OnCoCross | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩115.02B | 1.92 | ₩10,060 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kang Stem Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩110.59B | -11.6x | -0.15 | ₩2,035 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharos IBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩105.9B | -9.6x | 4.68 | ₩8,490 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cytogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩103.7B | -6.6x | -0.35 | ₩4,380 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shaperon | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩103.09B | -5.2x | 0.27 | ₩3,435 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellid | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩102.98B | -8.1x | -0.2 | ₩4,990 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ADM Korea | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩102.74B | -3.9x | 0.01 | ₩2,510 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cell Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩97.53B | 8.9x | 0 | ₩13,990 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curacle Co | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩94.2B | -5.3x | 0.1 | ₩6,930 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |